LPX-TI641 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting
Phase 1
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)
LAPIX Therapeutics Inc.48 enrolled1 locationNCT06628206